Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.

Oude Lashof, A M L; Sobel, J D; Ruhnke, M; Pappas, P G; Viscoli, C; Schlamm, H T; Rex, J H; Kullberg, B J

Oude Lashof, A M L; Sobel, J D; Ruhnke, M; Pappas, P G; Viscoli, C; Schlamm, H T; Rex, J H; Kullberg, B J.

Affiliation

Oude Lashof AM; Radboud University Nijmegen Medical Center and Nijmegen Institute for Infection, Inflammation, and Immunity (N4i), Nijmegen, The Netherlands.

Antimicrob Agents Chemother ; 56(6): 3133-7, 2012 Jun.

Article in En | MEDLINE | ID: mdl-22450974

Subject(s)

Antifungal Agents/adverse effects; Antifungal Agents/therapeutic use; Candidemia/drug therapy; Pyrimidines/adverse effects; Pyrimidines/therapeutic use; Renal Insufficiency/complications; Triazoles/adverse effects; Triazoles/therapeutic use; Adult; Aged; Aged, 80 and over; Female; Humans; Male; Middle Aged; Retrospective Studies; Voriconazole; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Triazoles / Renal Insufficiency / Candidemia / Antifungal Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google